Search Results - "Ohnstad, Hege O"

Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up by Ohnstad, Hege O, Borgen, Elin, Falk, Ragnhild S, Lien, Tonje G, Aaserud, Marit, Sveli, My Anh T, Kyte, Jon A, Kristensen, Vessela N, Geitvik, Gry A, Schlichting, Ellen, Wist, Erik A, Sørlie, Therese, Russnes, Hege G, Naume, Bjørn

“…The aim of this study was to investigate the prognostic value of the PAM50 intrinsic subtypes and risk of recurrence (ROR) score in patients with early breast…”
Get full text

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines by Ohnstad, Hege O, Paulsen, Erik B, Noordhuis, Paul, Berg, Marianne, Lothe, Ragnhild A, Vassilev, Lyubomir T, Myklebost, Ola

“…Frequent failure and severe side effects of current sarcoma therapy warrants new therapeutic approaches. The small-molecule MDM2 antagonist Nutlin-3a activates…”
Get full text

LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization by Kresse, Stine H., Ohnstad, Hege O., Paulsen, Erik B., Bjerkehagen, Bodil, Szuhai, Karoly, Serra, Massimo, Schaefer, Karl‐Ludwig, Myklebost, Ola, Meza‐Zepeda, Leonardo A.

“…Osteosarcomas are the most common primary malignant tumor of bone, and almost all conventional osteosarcomas are high‐grade tumors with complex karyotypes. We…”
Get full text

Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas by MEZA-ZEPEDA, Leonardo A, KRESSE, Stine H, BARRAGAN-POLANIA, Ana H, BJERKEHAGEN, Bodil, OHNSTAD, Hege O, NAMLES, Heidi M, JUNBAI WANG, KRISTIANSEN, Bjørn E, MYKLEBOST, Ola

“…Leiomyosarcomas are spindle cell tumors showing smooth muscle differentiation. Until recently, most gastrointestinal stromal tumors (GIST) were also classified…”
Get full text

Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome? by Ohnstad, Hege O, Bruland, Oyvind S, Taksdal, Ingeborg, Bjerkehagen, Bodil, Nenadovic, Maja, Sæter, Gunnar, Jørgensen, Lars H, Hall, Kirsten Sundby

“…Approximately 50% of patients with high-grade soft tissue sarcoma (STS) will develop pulmonary metastasis. This is the most frequent cause of death and…”
Get more information

DNA copy number changes in human malignant fibrous histiocytomas by array comparative genomic hybridisation by Kresse, Stine H, Ohnstad, Hege O, Bjerkehagen, Bodil, Myklebost, Ola, Meza-Zepeda, Leonardo A

“…Malignant fibrous histiocytomas (MFHs), or undifferentiated pleomorphic sarcomas, are in general high-grade tumours with extensive chromosomal aberrations. In…”
Get full text

DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH by Kresse, Stine H, Skårn, Magne, Ohnstad, Hege O, Namløs, Heidi M, Bjerkehagen, Bodil, Myklebost, Ola, Meza-Zepeda, Leonardo A

“…Malignant peripheral nerve sheath tumors (MPNSTs) are rare and highly aggressive soft tissue tumors showing complex chromosomal aberrations. In order to…”
Get full text

Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma by Ohnstad, Hege O., Castro, Russell, Sun, Jinchang, Heintz, Karen‐Marie, Vassilev, Lyubomir T., Bjerkehagen, Bodil, Kresse, Stine H., Meza‐Zepeda, Leonardo A., Myklebost, Ola

“…BACKGROUND: Relatively few sarcomas harbor TP53 (tumor protein p53) mutations, but in many cases, amplification of MDM2 (murine double minute 2) effectively…”
Get full text